Extracellular Vesicle-based Delivery of Paclitaxel to Lung Cancer Cells: Uptake, Anticancer Effects, Autophagy and Mitophagy Pathways
Authors:
- 7 February 2025
- journal article
- Published by Elsevier in Archives of Medical Research
- Vol. 56 (4) , 103194
Abstract
No abstract availableKeywords
Funding Information
- Urmia University
This publication has 44 references indexed in Scilit:
- Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approachesJournal of Extracellular Vesicles, 2024
- Oil Red O based method for exosome labelling and detectionBiochemical and Biophysical Research Communications, 2022
- Gambogic acid potentiates gemcitabine induced anticancer activity in non-small cell lung cancerEuropean Journal of Pharmacology, 2020
- Exosomes as drug delivery vehicle and contributor of resistance to anticancer drugsCancer Letters, 2020
- Tannic acid-inspired paclitaxel nanoparticles for enhanced anticancer effects in breast cancer cellsJournal of Colloid and Interface Science, 2019
- Ketoconazole exacerbates mitophagy to induce apoptosis by downregulating cyclooxygenase-2 in hepatocellular carcinomaJournal of Hepatology, 2019
- Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cellsNanomedicine: Nanotechnology, Biology and Medicine, 2016
- Combining magnetic nanoparticles with cell derived microvesicles for drug loading and targetingNanomedicine: Nanotechnology, Biology and Medicine, 2015
- Carboxymethyl-β-cyclodextrin conjugated nanoparticles facilitate therapy for folate receptor-positive tumor with the mediation of folic acidInternational Journal of Pharmaceutics, 2014
- Inhibition of autophagy by 3-MA potentiates cisplatin-induced apoptosis in esophageal squamous cell carcinoma cellsMedical Oncology, 2009